Literature DB >> 8721738

Synthesis and iron binding studies of myo-inositol 1,2,3-trisphosphate and (+/-)-myo-inositol 1,2-bisphosphate, and iron binding studies of all myo-inositol tetrakisphosphates.

I D Spiers1, C J Barker, S K Chung, Y T Chang, S Freeman, J M Gardiner, P H Hirst, P A Lambert, R H Michell, D R Poyner, C H Schwalbe, A W Smith, K R Solomons.   

Abstract

The first syntheses of the natural products myo-inositol 1,2,3-trisphosphate and (+/-)-myo-inositol 1,2-bisphosphate are described. The protected key intermediates 4,5,6-tri-O-benzoyl-myo-inositol and (+/-)-3,4,5,6-tetra-O-benzyl-myo-inositol were phosphorylated with dibenzyl N,N-di-isopropylphosphoramidite in the presence of 1H-tetrazole and subsequent oxidation of the phosphite. The crystal structures of the synthetic intermediates (+/-)-1-O-(tert-butyldiphenylsilyl)-2,3,O-cyclohexylidene-myo-inos itol and (+/-)-4,5,6-tri-O-benzoyl-1-O-(tert-butyldiphenylsilyl)-2,3-O-cycl ohexylidene- myo-inositol are reported. myo-Inositol 1,2,3-trisphosphate, (+/-)-myo-inositol 1,2-bisphosphate, and all isomeric myo-inositol tetrakisphosphates were evaluated for their ability to alter HO. production in the iron-catalysed Haber-Weiss reaction. The results demonstrated that a 1,2,3-grouping of phosphates in myo-inositol was necessary for inhibition, also that (+/-)-myo-inositol 1,2-bisphosphate potentiated HO. production. myo-Inositol 1,2,3-trisphosphate resembled myo-inositol hexakisphosphate (phytic acid) in its ability to act as a siderophore by promoting iron-uptake into Pseudomonas aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8721738     DOI: 10.1016/0008-6215(95)00361-4

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  5 in total

1.  Inositide evolution - towards turtle domination?

Authors:  Robin F Irvine
Journal:  J Physiol       Date:  2005-04-28       Impact factor: 5.182

2.  "Chelatable iron pool": inositol 1,2,3-trisphosphate fulfils the conditions required to be a safe cellular iron ligand.

Authors:  Nicolás Veiga; Julia Torres; David Mansell; Sally Freeman; Sixto Domínguez; Christopher J Barker; Alvaro Díaz; Carlos Kremer
Journal:  J Biol Inorg Chem       Date:  2008-09-02       Impact factor: 3.358

3.  Complex changes in cellular inositol phosphate complement accompany transit through the cell cycle.

Authors:  Christopher J Barker; Joanne Wright; Philip J Hughes; Christopher J Kirk; Robert H Michell
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

4.  The behaviour of inositol 1,3,4,5,6-pentakisphosphate in the presence of the major biological metal cations.

Authors:  Nicolás Veiga; Julia Torres; Himali Y Godage; Andrew M Riley; Sixto Domínguez; Barry V L Potter; Alvaro Díaz; Carlos Kremer
Journal:  J Biol Inorg Chem       Date:  2009-05-05       Impact factor: 3.358

5.  Influence of pH on the Cytotoxic Activity of Inositol Hexakisphosphate (IP6) in Prostate Cancer.

Authors:  Blandine Betton; Philippe O Gannon; Ismaël Hervé Koumakpayi; Jean-Simon Diallo; Anne-Marie Mes-Masson; Fred Saad
Journal:  Front Oncol       Date:  2011-10-31       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.